相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The past, present and future of anti-malarial medicines
Edwin G. Tse et al.
MALARIA JOURNAL (2019)
Artemisinin-(Iso)quinoline Hybrids by C-H Activation and Click Chemistry: Combating Multidrug-Resistant Malaria
Aysun Capci et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Ferrocene-Based Compounds with Antimalaria/Anticancer Activity
Sijongesonke Peter et al.
MOLECULES (2019)
In vivo proof-of-concept for two experimental antiviral drugs, both directed to cellular targets, using a murine cytomegalovirus model
Eric Sonntag et al.
ANTIVIRAL RESEARCH (2019)
Artemisinin, the Magic Drug Discovered from Traditional Chinese Medicine
Jigang Wang et al.
ENGINEERING (2019)
Next-generation strategy for treating drug resistant bacteria: Antibiotic hybrids
Varsha Gupta et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2019)
Quinolone antibiotics
Thu D. M. Pham et al.
MEDCHEMCOMM (2019)
Access to new highly potent antileukemia, antiviral and antimalarial agents via hybridization of natural products (homo)egonol, thymoquinone and artemisinin
Aysun Capci Karagoez et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Synthesis of Artemisinin-Derived Dimers, Trimers and Dendrimers: Investigation of Their Antimalarial and Antiviral Activities Including Putative Mechanisms of Action
Tony Froehlich et al.
CHEMISTRY-A EUROPEAN JOURNAL (2018)
Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?
Ronald Domalaon et al.
CLINICAL MICROBIOLOGY REVIEWS (2018)
Molecular Consortia-Various Structural and Synthetic Concepts for More Effective Therapeutics Synthesis
Anna Pawelczyk et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Treatment of Multidrug-Resistant Leukemia Cells by Novel Artemisinin-, Egonol-, and Thymoquinone-Derived Hybrid Compounds
Lisa Gruber et al.
MOLECULES (2018)
A Tobramycin Vector Enhances Synergy and Efficacy of Efflux Pump Inhibitors against Multidrug-Resistant Gram-Negative Bacteria
Xuan Yang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Quinoline-Based Hybrid Compounds with Antimalarial Activity
Xhamla Nqoro et al.
MOLECULES (2017)
Facile access to potent antiviral quinazoline heterocycles with fluorescence properties via merging metal-free domino reactions
Felix E. Held et al.
NATURE COMMUNICATIONS (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Hybrid Drugs as Potential Combatants Against Drug-Resistant Microbes: A Review
Haythem A. Saadeh et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2017)
Adjuvants Based on Hybrid Antibiotics Overcome Resistance in Pseudomonas aeruginosa and Enhance Fluoroquinolone Efficacy
Bala Kishan Gorityala et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
In vitro antimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteria
Akinobu Ito et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
A Hybrid Drug Limits Resistance by Evading the Action of the Multiple Antibiotic Resistance Pathway
Kathy K. Wang et al.
MOLECULAR BIOLOGY AND EVOLUTION (2016)
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study
Nicholas Butowski et al.
NEURO-ONCOLOGY (2016)
Design and synthesis of a C7-aryl piperlongumine derivative with potent antimicrotubule and mutant p53-reactivating properties
Surendra R. Punganuru et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Synthesis and evaluation of novel hybrids β-carboline-4-thiazolidinones as potential antitumor and antiviral agents
Valeria Aquilino Barbosa et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Linkers Having a Crucial Role in Antibody-Drug Conjugates
Jun Lu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Randomized Open-Label Phase II Trial of Apitolisib (GDC-0980), a Novel Inhibitor of the PI3K/Mammalian Target of Rapamycin Pathway, Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma
Thomas Powles et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Hybrid Antibiotic Overcomes Resistance in P. aeruginosa by Enhancing Outer Membrane Penetration and Reducing Efflux
Bala Kishan Gorityala et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Artemisinin-Derived Dimers: Potent Antimalarial and Anticancer Agents
Tony Frohlich et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Safety, tolerability, and preliminary activity of CUDC-907, a first-in-class, oral, dual inhibitor of HDAC and PI3K, in patients with relapsed or refractory lymphoma or multiple myeloma: an open-label, dose-escalation, phase 1 trial
Anas Younes et al.
LANCET ONCOLOGY (2016)
Pharmacodynamic Profiling of a Siderophore-Conjugated Monocarbam in Pseudomonas aeruginosa: Assessing the Risk for Resistance and Attenuated Efficacy
Aryun Kim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Potentiation of Antibacterial Activity of the MB-1 Siderophore-Monobactam Conjugate Using an Efflux Pump Inhibitor
Andrew P. Tomaras et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Influence of length and flexibility of spacers on the binding affinity of divalent ligands
Susanne Liese et al.
BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY (2015)
Highly potent artemisinin-derived dimers and trimers: Synthesis and evaluation of their antimalarial, antileukemia and antiviral activities
Christoph Reiter et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Design, synthesis, optimization and antiviral activity of a class of hybrid dengue virus E protein inhibitors
Surender Singh Jadav et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma
Thomas J. Galloway et al.
CLINICAL CANCER RESEARCH (2015)
New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4-trioxane-ferrocene hybrids
Christoph Reiter et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
A review on pharmacophoric designs of antiproliferative agents
Anil Rana et al.
MEDICINAL CHEMISTRY RESEARCH (2015)
Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids
Kunal Nepali et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Design, synthesis, and evaluation of novel fluoroquinolone-flavonoid hybrids as potent antibiotics against drug-resistant microorganisms
Zhu-Ping Xiao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Synthesis and study of cytotoxic activity of 1,2,4-trioxane- and egonol-derived hybrid molecules against Plasmodium falciparum and multidrug-resistant human leukemia cells
Christoph Reiter et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Siderophore-dependent iron uptake systems as gates for antibiotic Trojan horse strategies against Pseudomonas aeruginosa
Gaetan L. A. Mislin et al.
METALLOMICS (2014)
Initial Testing (Stage 1) of the Histone Deacetylase Inhibitor, Quisinostat (JNJ-26481585), by the Pediatric Preclinical Testing Program
Hernan Carol et al.
PEDIATRIC BLOOD & CANCER (2014)
Synthesis and evaluation of artesunate-indoloquinoline hybrids as antimalarial drug candidates
Ning Wang et al.
MEDCHEMCOMM (2014)
Profile of vintafolide (EC145) and its use in the treatment of platinum-resistant ovarian cancer
Mathieu Luyckx et al.
INTERNATIONAL JOURNAL OF WOMENS HEALTH (2014)
Overview of the therapeutic potential of piplartine (piperlongumine)
Daniel P. Bezerra et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Advances in the development of hybrid anticancer drugs
Sebastien Fortin et al.
EXPERT OPINION ON DRUG DISCOVERY (2013)
Clinical relevance of the ESKAPE pathogens
Jack N. Pendleton et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2013)
A primaquine-chloroquine hybrid with dual activity against Plasmodium liver and blood stages
Melanie Loedige et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2013)
Structural Characteristics of Chloroquine-Bridged Ferrocenophane Analogues of Ferroquine May Obviate Malaria Drug-Resistance Mechanisms
Paloma F. Salas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Antimalarial and anticancer activities of artemisinin-quinoline hybrid-dimers and pharmacokinetic properties in mice
Marli C. Lombard et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Design, Synthesis, and Antiviral Evaluation of Purine-β-lactam and Purine-aminopropanol Hybrids
Matthias D'hooghe et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Modular Synthesis of 1,2- and 1,1′-Disubstituted Ferrocenyl Carbohydrate Chloroquine and Mefloquine Conjugates as Potential Antimalarial Agents
Christoph Herrmann et al.
ORGANOMETALLICS (2012)
Prodrugs for improving tumor targetability and efficiency
Rubi Mahato et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
The Application of Tandem Aza-Wittig Reaction to Synthesize Artemisinin-Guanidine Hybrids and Their Anti-Tumor Activity
Lijun Xie et al.
ARCHIV DER PHARMAZIE (2011)
Synthesis and in vitro antiplasmodial activityof quinoline-ferrocene esters
David N-Da et al.
ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH (2011)
THE ANTIMALARIAL FERROQUINE: FROM BENCH TO CLINIC
C. Biot et al.
PARASITE (2011)
A Cleavable Linker Based on the Levulinoyl Ester for Activity-Based Protein Profiling
Paul P. Geurink et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Artemisinin-quinoline hybrid-dimers: Synthesis and in vitro antiplasmodial activity
Marli C. Lombard et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
CUDC-101, a Multitargeted Inhibitor of Histone Deacetylase, Epidermal Growth Factor Receptor, and Human Epidermal Growth Factor Receptor 2, Exerts Potent Anticancer Activity
Cheng-Jung Lai et al.
CANCER RESEARCH (2010)
Artemisinin Resistance in Cambodia: A Clinical Trial Designed to Address an Emerging Problem in Southeast Asia
Harald Noedl et al.
CLINICAL INFECTIOUS DISEASES (2010)
Discovery of 7-(4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide (CUDC-101) as a Potent Multi-Acting HDAC, EGFR, and HER2 Inhibitor for the Treatment of Cancer
Xiong Cai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Recent Progress in the Development of Synthetic Hybrids of Natural or Unnatural Bioactive Compounds for Medicinal Chemistry
Svetlana B. Tsogoeva
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2010)
The Molecular Mechanism of Action of Artemisinin-The Debate Continues
Paul M. O'Neill et al.
MOLECULES (2010)
Plasmodium falciparum Drug Resistance in Madagascar: Facing the Spread of Unusual pfdhfr and pfmdr-1 Haplotypes and the Decrease of Dihydroartemisinin Susceptibility
Valerie Andriantsoanirina et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Antiprotozoal, anticancer and antimicrobial activities of dihydroartemisinin acetal dimers and monomers
Desmond Slade et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Hybrid Drugs for Malaria
J. J. Walsh et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Design, Synthesis, and Evaluation of Novel Fluoroquinolone-Aminoglycoside Hybrid Antibiotics
Varvara Pokrovskaya et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Hybrid molecules with a dual mode of action: Dream or reality?
Bernard Meunier
ACCOUNTS OF CHEMICAL RESEARCH (2008)
Patent issues relating to hybrid drugs
John Richards
EXPERT OPINION ON THERAPEUTIC PATENTS (2008)
Drug interactions modulate the potential for evolution of resistance
Jean-Baptiste Michel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A novel artemisinin-quinine hybrid with potent antimalarial activity
John J. Walsh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
The physicochemical challenges of designing multiple ligands
Richard Morphy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Defining the role of PfCRT in Plasmodium falciparum chloroquine resistance
PG Bray et al.
MOLECULAR MICROBIOLOGY (2005)
Enzyme-cleavable linkers for peptide and glycopeptide synthesis
BA Maltman et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2005)
Antimalarial and antitumor evaluation of novel C-10 non-acetal dimers of 10β-(2-hydroxyethyl)deoxoartemisinin
JP Jeyadevan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Mechanism of action of NB2001 and NB2030, novel antibacterial agents activated by β-lactamases
GW Stone et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
From magic bullets to designed multiple ligands
R Morphy et al.
DRUG DISCOVERY TODAY (2004)
Plasmepsin II inhibition and antiplasmodial activity of primaquine-statine 'double-drugs'
S Romeo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Antitumor activity of novel deoxoartemisinin monomers, dimers, and trimer
M Jung et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Natural product hybrids as new leads for drug discovery
LF Tietze et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2003)
Application of the bivalent ligand approach to the design of novel dimeric serotonin reuptake inhibitors
AP Tamiz et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2000)
分享论文
